Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (6): 38-44.doi: 10.6040/j.issn.1673-3770.0.2022.186

• 临床研究 • Previous Articles    

Current status of comprehensive pathway management atrial fibrillation before cataract surgery: a cross-sectional survey

LI Aijun, CUI Xiaomei   

  1. Department of Geriatrics, Beijing Tong Ren Hospital, Capital Medical University, Beijing 100730, China
  • Published:2022-12-07

PDF (PC)

110

Abstract: Objective To investigate the status of comprehensive pathway management of atrial fibrillation and stroke cognition in a pre-cataract atrial fibrillation population, analyze the associated risk factors, optimize and promote comprehensive pathway management, and prevent and reduce the risk of stroke. Methods From June 2021 to March 2022, a self-made questionnaire on the comprehensive pathway management of atrial fibrillation and stroke cognition was provided to patients with atrial fibrillation before cataract surgery. The CHA2DS2-VASc score was used for statistical analysis using the SPSS 22.0 statistical software. Results We distributed 133 self-made questionnaires on comprehensive pathway management of atrial fibrillation and stroke cognition, and recovered 133 valid responses; the effective rate was 100%. The age of the investigated preoperative atrial fibrillation population was 60-95 years old,(average age: 76.83±7.452 years), and the prevalence rate of atrial fibrillation was 1.44%. The number of patients with atrial fibrillation increased with age, with more men than women. The awareness rate of comprehensive pathway management and the stroke awareness rate in the pre-cataract atrial fibrillation population was 36.09%, and patients who followed the comprehensive pathway management accounted for 12.03%. The anticoagulation/antiplatelet treatment, rhythm control treatment, and stroke rates were 36.09%, 64.66%, and 11.28%, respectively, while 61.65% of the patients with atrial fibrillation before cataract surgery had concomitant diseases, and 24.06% had two or more concomitant diseases simultaneously. Among 133 patients with atrial fibrillation, 66.17% had unsatisfactory disease control, 59.40% had unhealthy lifestyles, and 54.88% had bad habits. High-risk patients accounted for 73.68% in the CHA2DS2-VASc score. Conclusion Among elderly individuals who experience atrial fibrillation before cataract surgery, along with poor awareness of comprehensive management of atrial fibrillation, lack of knowledge about stroke, low rate of early anticoagulation treatment after the identification of atrial fibrillation, many concomitant diseases and unsatisfactory control, unhealthy lifestyle and bad habits are major and potential risk factors for stroke. Cataract and atrial fibrillation patients with a history of stroke who do not follow the comprehensive pathway management are at high risk of re-stroke. Health education on atrial fibrillation cognition in pre-cataract patients with atrial fibrillation should be reinforced to guide optimization and promote comprehensive pathway management strategies.

Key words: Cataract surgery, Atrial fibrillation population, Comprehensive pathway management, Current status, Risk factor analysis

CLC Number: 

  • R779.66
[1] Odutayo A, Wong CX, Hsiao AJ, et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis[J]. BMJ, 2016, 354: i4482. doi:10.1136/bmj.i4482.
[2] Lin T, Wissner E, Tilz R, et al. Preserving cognitive function in patients with atrial fibrillation[J]. J Atr Fibrillation, 2014, 7(1): 980. doi:10.4022/jafib.980.
[3] Mendis S. Stroke disability and rehabilitation of stroke: world Health Organization perspective[J]. Int J Stroke, 2013, 8(1): 3-4. doi:10.1111/j.1747-4949.2012.00969.x.
[4] Sepehri Shamloo A, Dagres N, Hindricks G. 2020 ESC guidelines on atrial fibrillation: summary of the most relevant recommendations and innovations[J]. Herz, 2021, 46(1): 28-37. doi:10.1007/s00059-020-05005-y.
[5] 俞娅娅, 李小荣, 余金波, 等. 心房颤动综合管理ABC方案[J]. 中国心脏起搏与心电生理杂志, 2020, 34(1): 7-10. doi:10.13333/j.cnki.cjcpe.2020.01.003. YU Yaya, LI Xiaorong, YU Jinbo, et al. ABC scheme for comprehensive management of atrial fibrillation[J]. Chinese Journal of Cardiac Pacing and Electrophysiology, 2020, 34(1): 7-10. doi:10.13333/j.cnki.cjcpe.2020.01.003.
[6] Proietti M, Romiti GF, Olshansky B, et al. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC(atrial fibrillation better care)pathway[J]. Am J Med, 2018, 131(11): 1359-1366.e6. doi:10.1016/j.amjmed.2018.06.012.
[7] Harding BN, Norby FL, Heckbert SR, et al. Longitudinal measures of blood pressure and subclinical atrial arrhythmias: the MESA and the ARIC study[J]. J Am Heart Assoc, 2021, 10(11): e020260. doi:10.1161/JAHA.120.020260.
[8] Sobieraj P, Nilsson PM, Kahan T. Heart failure events in a clinical trial on arterial hypertension: new insights into the SPRINT trial[J]. Hypertension, 2021, 78(5): 1241-1247. doi:10.1161/HYPERTENSIONAHA.121.17360.
[9] 李烽, 李晓燕, 王如兴. 血糖波动对心房颤动发生的影响及其机制研究进展[J]. 中华心律失常学杂志, 2021, 25(3): 236-238. doi:10.3760/cma.j.cn.113859-20201113-00292. LI Feng, LI Xiaoyan, WANG Ruxing. Research progress of glucose fluctuations on the occurrence of atrial fibrillation and its mechanism[J]. Chinese Journal of Cardiac Arrhythmias, 2021, 25(3): 236-238. doi:10.3760/cma.j.cn.113859-20201113-00292.
[10] Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction[J]. JAMA Intern Med, 2014, 174(1): 107-114. doi:10.1001/jamainternmed.2013.11912.
[11] 史晓宁, 王晴晴, 白婷婷, 等. 脑卒中高危人群健康行为及影响因素分析[J]. 全科护理, 2014, 12(10): 934-935, 943. doi:10.3969/j.issn.1674-4748.2014.10.043. SHI Xiaoning, WANG Qingqing, BAI Tingting, et al. Analysis of health behaviors and influencing factors of high-risk population with stroke[J]. Chinese General Practice Nursing, 2014, 12(10): 934-935, 943. doi:10.3969/j.issn.1674-4748.2014.10.043.
[12] Morris A, Elder MJ. Warfarin therapy and cataract surgery[J]. Clin Exp Ophthalmol, 2000, 28(6): 419-422. doi:10.1046/j.1442-9071.2000.00350.x.
[13] Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery[J]. Ophthalmology, 2003, 110(9): 1784-1788. doi:10.1016/S0161-6420(03)00785-1.
[14] Barequet IS, Sachs D, Shenkman B, et al. Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy[J]. J Cataract Refract Surg, 2011, 37(8): 1434-1438. doi:10.1016/j.jcrs.2011.02.035.
[15] Kobayashi H. Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery[J]. J Cataract Refract Surg, 2010, 36(7): 1115-1119. doi:10.1016/j.jcrs.2010.01.017.
[16] Steffel J, Collins R, Antz M, et al. 2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Europace, 2021, 23(10): 1612-1676. doi:10.1093/europace/euab065.
[17] Unverdorben M, von Heymann C, Santamaria A, et al. Elderly patients with atrial fibrillation in routine clinical practice-peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study[J]. BMC Cardiovasc Disord, 2020, 20(1): 504. doi:10.1186/s12872-020-01766-w.
[18] Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J, 2016, 37(38): 2893-2962. doi:10.1093/eurheartj/ehw210.
[19] January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons[J]. Circulation, 2019, 140(2): e125-e151. doi:10.1161/CIR.0000000000000665.
[20] Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J, 2016, 37(38): 2893-2962. doi:10.1093/eurheartj/ehw210.
[21] Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation[J]. Heart, 2020, 106(1): 10-17. doi:10.1136/heartjnl-2019-314898.
[22] 董艳, 李小荣, 周秀娟, 等. 心房颤动抗凝治疗的指南更新和实践运用[J]. 中国心脏起搏与心电生理杂志, 2019, 33(2): 95-99. doi:10.13333/j.cnki.cjcpe.2019.02.001. DONG Yan, LI Xiaorong, ZHOU Xiujuan, et al. Chinese Journal of Cardiac Pacing and Electrophysiology[J]. Chinese Journal of Cardiac Pacing and Electrophysiology, 2019, 33(2): 95-99. doi:10.13333/j.cnki.cjcpe.2019.02.001.
[23] 张澍, 杨艳敏, 黄从新, 等. 中国心房颤动患者卒中预防规范(2017)[J]. 中华心律失常学杂志, 2018(1): 17-30. doi:10.3760/cma.j.issn.1007-6638.2018.01.006. ZHANG Shu, YANG Yanmin, HUANG Congxin, et al. Guideline of stroke prevention in Chinese patients with atrial fibrillation(2017)[J]. Chinese Journal of Cardiac Arrhythmias, 2018(1): 17-30. doi:10.3760/cma.j.issn.1007-6638.2018.01.006.
[24] Bassand JP, Apenteng PN, Atar D, et al. GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke[J]. Future Cardiol, 2021, 17(1): 19-38. doi:10.2217/fca-2020-0014.
[25] Kim D, Yang PS, You SC, et al. Comparative effectiveness of early rhythm control versus rate control for cardiovascular outcomes in patients with atrial fibrillation[J]. J Am Heart Assoc, 2021, 10(24): e023055. doi:10.1161/JAHA.121.023055.
[26] Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation[J]. N Engl J Med, 2020, 383(14): 1305-1316. doi:10.1056/nejmoa2019422.
[27] Yang E, Marine JE. Reply to the Editor-Clinical phenotypes of AF patients enrolled in RCTs: AFFIRM and EAST-AFNET 4[J]. Heart Rhythm, 2021, 18(10): 1813. doi:10.1016/j.hrthm.2021.05.025.
[28] Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation[J]. N Engl J Med, 2019, 381(20): 1909-1917. doi:10.1056/NEJMoa1901183.
[29] Staerk L, Wang BQ, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study[J]. BMJ, 2018, 361: k1453. doi:10.1136/bmj.k1453.
[30] Jiang C, Lan DH, Du X, et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: a report from the China atrial fibrillation registry study[J]. J Cardiovasc Electrophysiol, 2019, 30(12): 2759-2766. doi:10.1111/jce.14231.
[31] 张筑欣, 马长生. 心房颤动的综合管理[J]. 中国实用内科杂志, 2020, 40(3): 177-181. doi:10.19538/j.nk2020030101. ZHANG Zhuxin, MA Changsheng. Comprehensive management of atrial fibrillation[J]. Chinese Journal of Practical Internal Medicine, 2020, 40(3): 177-181. doi:10.19538/j.nk2020030101.
[32] Pastori D, Farcomeni A, Pignatelli P, et al. ABC(atrial fibrillation better care)pathway and healthcare costs in atrial fibrillation: the ATHERO-AF study[J]. Am J Med, 2019, 132(7): 856-861. doi:10.1016/j.amjmed.2019.01.003.
[33] Pokorney SD, Piccini JP. Treatment of atrial fibrillation: is it as easy as A-B-C? [J]. Europace, 2021, 23(2): 161-162. doi:10.1093/europace/euaa361.
[34] Abadie BQ, Hansen B, Walker J, et al. An atrial fibrillation transitions of care clinic improves atrial fibrillation quality metrics[J]. JACC Clin Electrophysiol, 2020, 6(1): 45-52. doi:10.1016/j.jacep.2019.09.001.
[1] DUAN Lian, MENG FanlanReview,DANG GuangfuGuidance. Effect of dry eye on refractive cataract surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 1-6.
[2] TAN Yan, LI Can. Progress in the research of intraocular lens power calculation formulas [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 95-98.
[3] TANG Wei, LI Yuanbin. New progress in refractive cataract surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 149-158.
[4] BI Hongsheng. Design of treatment protocol in refractive cataract surgery is important for postoperative visual outcomes. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 1-4.
[5] SUN Hong-yi, ZHANG Han. Changes of macular thickness under optical coherent tomography in type 2 diabetic patients with cataract after phacoemulsification surgery and IOL implantation [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(6): 72-76.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd